Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.138NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.255NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.303NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.173NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.362.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.520NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.521NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCGNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DT.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCANWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GN.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.77 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.53 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.576NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.325NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.521NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.378NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.206NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.403NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.636NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19061.8South Korea
B.1.126NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDQ.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JD.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.31.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CK.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.8.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CA.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ED.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used